Literature DB >> 11679949

Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report.

E Reusche1, P Pilz, G Oberascher, B Lindner, R Egensperger, K Gloeckner, E Trinka, B Iglseder.   

Abstract

We report a 52-year-old woman who underwent otoneurosurgery to resect acoustic neurinoma. Bone reconstruction was performed with an aluminium (Al)-containing cement. Six weeks later the patient suffered from loss of consciousness, myoclonic jerks, and persistent grand mal seizures, clinical symptoms that resembled those of lethal dialysis encephalopathy of the 1960s and 1970s. She died 6 months later because of septic complications. Light- and electron-microscopic investigation of the central nervous system (CNS) showed pathognomonic Al-containing intracytoplasmic argyrophilic inclusions in choroid plexus epithelia, neurons, and cortical glia. These changes are characteristics of dialysis-associated encephalopathy (DAE), induced nowadays by long-term ingestion of Al-containing drugs (and with benign clinical courses). Atomic absorption spectrometry showed an increase of mean bulk Al concentration of the cortex and subcortex up to 9.3 microg/g (normal range <2 microg/g); laser microprobe showed the increase of Al in subcellular structures. This unique case again shows the extraordinary neurotoxicity of Al, which was, in our patient, initiated by an amount of about 30 mg Al and apparently caused by direct Al access to the brain parenchyma via a cerebrospinal fluid leakage. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679949     DOI: 10.1053/hupa.2001.28251

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

1.  The processing, mechanical properties and bioactivity of zinc based glass ionomer cements.

Authors:  D Boyd; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2005-09       Impact factor: 3.896

2.  Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UK.

Authors:  C Exley; M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-20       Impact factor: 10.154

Review 3.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

4.  The effect of glass synthesis route on mechanical and physical properties of resultant glass ionomer cements.

Authors:  A Wren; O M Clarkin; F R Laffir; C Ohtsuki; I Y Kim; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2009-05-21       Impact factor: 3.896

5.  Characteristics of glass ionomer cements composed of glass powders in CaO-SrO-ZnO-SiO₂ system prepared by two different synthetic routes.

Authors:  Ill Yong Kim; Chikara Ohtsuki; Aisling Coughlan; Lana Placek; Anthony W Wren; Mark R Towler
Journal:  J Mater Sci Mater Med       Date:  2013-08-07       Impact factor: 3.896

6.  The use of bone cement for ossicular chain defects.

Authors:  M Tayyar Kalcioglu; Mehmet Tan; Jelle Fleerakkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-03       Impact factor: 2.503

7.  Degradable borate glass polyalkenoate cements.

Authors:  L Shen; A Coughlan; M Towler; M Hall
Journal:  J Mater Sci Mater Med       Date:  2014-01-17       Impact factor: 3.896

Review 8.  A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders.

Authors:  Virginie Rondeau
Journal:  Rev Environ Health       Date:  2002 Apr-Jun       Impact factor: 3.458

9.  Comparison of an experimental bone cement with a commercial control, Hydroset.

Authors:  O M Clarkin; D Boyd; S Madigan; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2009-02-13       Impact factor: 3.896

10.  Comparison of failure mechanisms for cements used in skeletal luting applications.

Authors:  O Clarkin; D Boyd; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2009-03-13       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.